Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Diabetes Research and Clinical Practice
|
May 23, 2008
Prevalence of diabetes mellitus and metabolic syndrome in Slovakia
Marián Mokán, Peter Galajda, Dana Prídavková, et al.
Drugs & Aging
|
May 9, 2018
Dabigatran Levels in Elderly Patients with Atrial Fibrillation: First Post-Marketing Experiences
Tomáš Bolek, Matej Samoš, Ingrid Škorňová, et al.
Journal of Diabetes Research
|
January 30, 2016
Type 2 Diabetes and ADP Receptor Blocker Therapy
Matej Samoš, Marián Fedor, František Kovář, et al.
BMC Biology
|
November 29, 2022
Ecological succession and the competition-colonization trade-off in microbial communities
Miles T Wetherington, Krisztina Nagy, László Dér, et al.
Plos One
|
October 30, 2013
Spatial structure facilitates cooperation in a social dilemma: empirical evidence from a bacterial community
Felix J H Hol, Peter Galajda, Krisztina Nagy, et al.
Journal of Cardiovascular Pharmacology
|
May 9, 2018
Proton Pump Inhibition in Patients Treated With Novel Antithrombotic Drugs: Should We Worry About Thrombosis?
Tomáš Bolek, Matej Samoš, Ingrid Škorňová, et al.
Journal of Diabetes Research
|
March 17, 2022
Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
Jakub Benko, Matej Samoš, Tomáš Bolek, et al.
American Journal of Therapeutics
|
April 29, 2017
The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation
Tomáš Bolek, Matej Samoš, Lucia Stančiaková, et al.
International Journal of Endocrinology
|
January 20, 2016
The Intricate Network of Adipokines and Stroke
Ema Kantorová, Ľubica Jesenská, Daniel Čierny, et al.
Pharmacology Research & Perspectives
|
May 13, 2021
Does atorvastatin therapy change the anti-Xa activity in xabans-treated patients with atrial fibrillation?
Ingrid Škorňová, Matej Samoš, Tomáš Bolek, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Diabetes Research and Clinical Practice
|
May 23, 2008
Prevalence of diabetes mellitus and metabolic syndrome in Slovakia
Marián Mokán, Peter Galajda, Dana Prídavková, et al.
Drugs & Aging
|
May 9, 2018
Dabigatran Levels in Elderly Patients with Atrial Fibrillation: First Post-Marketing Experiences
Tomáš Bolek, Matej Samoš, Ingrid Škorňová, et al.
Journal of Diabetes Research
|
January 30, 2016
Type 2 Diabetes and ADP Receptor Blocker Therapy
Matej Samoš, Marián Fedor, František Kovář, et al.
BMC Biology
|
November 29, 2022
Ecological succession and the competition-colonization trade-off in microbial communities
Miles T Wetherington, Krisztina Nagy, László Dér, et al.
Plos One
|
October 30, 2013
Spatial structure facilitates cooperation in a social dilemma: empirical evidence from a bacterial community
Felix J H Hol, Peter Galajda, Krisztina Nagy, et al.
Journal of Cardiovascular Pharmacology
|
May 9, 2018
Proton Pump Inhibition in Patients Treated With Novel Antithrombotic Drugs: Should We Worry About Thrombosis?
Tomáš Bolek, Matej Samoš, Ingrid Škorňová, et al.
Journal of Diabetes Research
|
March 17, 2022
Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
Jakub Benko, Matej Samoš, Tomáš Bolek, et al.
American Journal of Therapeutics
|
April 29, 2017
The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation
Tomáš Bolek, Matej Samoš, Lucia Stančiaková, et al.
International Journal of Endocrinology
|
January 20, 2016
The Intricate Network of Adipokines and Stroke
Ema Kantorová, Ľubica Jesenská, Daniel Čierny, et al.
Pharmacology Research & Perspectives
|
May 13, 2021
Does atorvastatin therapy change the anti-Xa activity in xabans-treated patients with atrial fibrillation?
Ingrid Škorňová, Matej Samoš, Tomáš Bolek, et al.
Page
of 8